In November 2020 the SEC made several changes to the MD&A requirements in Regulation S-K Item 303. While many of the changes dealt with “modernization” clarifications and related details, others were more substantive in nature. Unfortunately, many companies did not implement the required changes to MD&A the year the rule became effective. As a result, the SEC has been issuing more and more comments focused on the rule’s substantive requirements. What has become clear, now is the time to be sure your MD&A appropriately deals with these requirements.
From recent SEC comments, we can observe that the SEC staff is currently focused on the following three areas of MD&A:
Critical accounting estimate disclosures
Quantitative and qualitative disclosures about material changes
Meaningfully addressing liquidity and capital resources
Here are example comments that demonstrate the staff’s concerns in each of these areas:
Critical accounting estimate disclosures
- In accordance with Item 303(b)(3), please provide a discussion and analysis
of critical accounting estimates and assumptions that:
-
-
- identifies your critical accounting estimates or assumptions;
• supplements, but does not duplicate, the description of accounting policies in the notes to the financial statements; and - provides greater insight into the quality and variability of information regarding financial condition and operating performance.
- identifies your critical accounting estimates or assumptions;
-
Quantitative and qualitative disclosures about material changes
- We note that you list multiple factors that contribute to changes in your results. For example, you disclose several factors contributing to the increase in voyage expense. Revise your disclosure to quantify each material factor that contributes to a change in your revenues or expenses. Refer to Item 303(b) of Regulation S-K.
Meaningfully addressing liquidity and capital resources
- Please discuss your material cash requirements from known contractual and other obligations as of December 31, 2021, the anticipated source of funds needed to satisfy such cash requirements and the relevant time period for the related cash requirements in accordance with Item 303(b)(1) of Regulation S-K. In this regard, we note you have purchase obligations relating to take-or pay contracts of approximately $283 million as of December 31, 2021. For further guidance refer to Instruction 4 to Item 303(b) of Regulation S-K.
All too often companies are reluctant or slow to change MD&A. The fear of SEC comments or other questions frequently impedes improving MD&A disclosure. However, in the current environment, exactly the opposite is true. Not making appropriate updates to MD&A may well result in SEC comments. These comments could easily be avoided by making appropriate updates.
In the next few posts, we will explore each area in detail, reviewing example disclosures and the comments they generated.
As always, your thoughts and comments are welcome.